PSMA-TB detected PCa in 21/25 (84.0%) and csPCa in 20/25 (80.0%) patients with PSMA-avid lesions, whereas TRUS-GB detected PCa in 19/60 (31.6%) (χ2 = 19.4, P < 0.01) and csPCa in 15/60 (25.0%) (χ2 = 22.0, P < 0.01) TRUS control patients. The gene discussed is FOLH1; the disease is posterior cortical atrophy.